The Practitioner 2010 – 254 (1730): 31-34

Tackling obesity in adults in primary care

23 Jun 2010

AUTHORS

Dr Jennifer Logue MBChB MRCP
Clinical lecturer in metabolic medicine

Professor Naveed Sattar MBChB PhD FRCPath
Professor of metabolic medicine

BHF Cardiovascular Research Centre, University of Glasgow

Article

Obesity is a growing problem and one which GPs will see many times in an average day. It may not be the main reason for the visit, but obesity is often a major contributing cause of disease, particularly diabetes and heart disease, and is also related to psychological disturbance and depression.

In England in 2008, 66% of men and 57% of women had a BMI >25 kg/m2; within this 24% of men and 25% of women were obese with a BMI >30 kg/m2. 1

The relative risk of diabetes in overweight men is 2.40 and in obese men 6.74 compared with men with a BMI in the normal range. The respective relative risks in women are 3.92 and 12.41.2

There is a 40% increased risk of death from cardiovascular disease for every 5 kg/m2 increase in BMI above 25 kg/m2. 3

While trying to tackle obesity may seem like very hard work for little gain, having a structured approach to dealing with overweight and obese patients will make it easier to broach the subject and enable evidence-based advice to be given that will be helpful to all patients.

Diagnosis

Overweight and obesity are diagnosed simply by use of the body mass index (BMI); this is calculated by dividing the weight (kg) by the square of the height (m). The WHO categories for BMI4 are shown in table 1.

BMI has been criticised for misclassifying people who are very muscular as overweight as it does not take account of fat mass, particularly abdominal fat which carries the highest risk for metabolic disease.

To get round this problem waist circumference has emerged as an alternative, or addition, to BMI for risk prediction. Measuring waist circumference can be cumbersome as it is virtually impossible to measure the same place each time, resulting in larger errors than BMI and it can also be intrusive for patients. However, recent studies have shown that BMI is just as good at predicting future risk of cardiovascular disease and death as waist circumference.5

When checking BMI, particularly in younger men, you should consider whether they are very muscular (the so-called rugby player physique) and apply commonsense. The majority of younger men, while being muscular, are not as muscular as professional sportsmen and are also carrying excess fat. Waist circumference is particularly helpful in these cases. Instructions for measuring waist circumference and cutoffs are given in table 2.4, 6

Certain ethnic groups including South Asians, Chinese and Japanese are at higher risk of adverse effects, such as diabetes, for a given BMI. For this reason lower BMI cutoffs have been proposed but a consensus has not yet been reached. Current thinking is that these individuals should be considered overweight at BMI >23 kg/m2 and obese at BMI>27.5 kg/m2, the waist circumference cutoff for men in these groups is 90 cm.7

Overweight and obesity is close to becoming a problem for the majority of the population. Some patients may come to the surgery specifically for advice on their weight, some may be receiving care for an obesity-related disease e.g. diabetes (but not receiving specific obesity management), while others may be attending for a different reason and not be aware that their weight is an issue. BMI is a simple test to perform and consideration should be given to monitoring patients' weight and offering guidance whenever appropriate.

Health risks

Obesity is a risk factor for many serious and complicated diseases. The increasing prevalence of obesity will bring huge excess costs to the NHS. Obesity is associated with an increased risk of:

  • diabetes8
  • cardiovascular disease - MI and stroke 9
  • fertility problems 10
  • fatty liver and cirrhosis 11
  • osteoarthritis and mobility problems 12
  • pregnancy and delivery complications 13
  • obstructive sleep apnoea 14
  • asthma 15

GP Management

Obesity treatment centres on lifestyle interventions. No obesity treatment will ever simply involve taking a tablet but instead involves gradual sustained changes in eating, food choices, and behaviour. The best evidence suggests that patients should be offered a combination of advice on dietary change and increasing physical activity which includes behavioural components.

In areas where referral to a formal weight management service is not available, dealing with this during a 10-minute appointment can seem impossible. However, most patients are usually well aware of where they are going wrong but find it difficult to change a habit of a lifetime.

Encouragement to make small changes in a sustained way can make significant differences to energy balance, see table 3, left. Explaining sources of hidden calories, such as high-sugar fruit drinks, low-fat yoghurts and ready prepared foods, along with encouraging patients to read food labels, also helps.

Physical activity targets can seem an impossible goal to many people; the current recommendation for sustained weight loss is 225-300 minutes a week of moderate intensity physical activity16 (increased heart rate and breathing but still able to converse). Examples of suitable physical activity include brisk walking or jogging, cycling, playing team sports such as football or hockey or participation in an aerobics class. It should be remembered that for some obese patients, simply walking will be exercise enough to increase heart rate and breathing.

The main message here is that unless you are going to do huge amounts of exercise, it is not enough alone to lose weight and dietary restriction is required. However, physical activity is good for health and wellbeing and small changes towards an active lifestyle will also burn calories.

Drug treatment is a useful addition when lifestyle measures alone are not effective; and should always be given along with, not instead of, lifestyle advice. Only orlistat is currently licensed for use in the UK, however, many new therapies are in development.

Bariatric surgery

There is increasing evidence for the effectiveness of bariatric surgery in treating obesity-related disease, particularly diabetes.17 There are two main procedures: gastric banding when an inflatable band is placed around the stomach reducing the space available for food, and gastric bypass where a small pouch of stomach is connected to the jejunum bypassing the duodenum and causing a degree of malabsorption. Both procedures are now thought to produce at least part of their effect through changes in gut hormone control of appetite. Gastric banding requires follow up to ensure that the band is correctly inflated to control appetite and deal with any complications of band slippage or erosion. Gastric bypass patients require lifelong nutritional monitoring.

Both NICE18 and SIGN16 have published evidence-based guidelines on the management of obesity.

The guidance recommends bariatric surgery for patients with obesity-related disease and a BMI >35 kg/m2, athough NICE also states that it should be available to those with a BMI >40 kg/m2 and no obesity-related comorbidities. However guidance and practice are very different. Routes of access for, and availability of, bariatric surgery vary across the country. Most bariatric surgical centres only take referrals from NHS weight management clinics and programmes and have strict criteria around attendance at appointments and attempts at preoperative weight loss. Only a very small proportion of the eligible population are being treated.

Weight management services

Obviously not every overweight and obese patient can be seen in a specialist weight management service. Local protocols apply as to which patients should be referred, but usually the focus is on those with severe and/or complicated obesity, such as patients with sleep apnoea, diabetes, mobility problems or a BMI >35 kg/m2.

There can be a mismatch between those patients who seek treatment and those with the greatest need and most to gain from treatment.

Men, individuals from deprived backgrounds and those with chronic disease should not be overlooked for weight management just because they are not seeking it; efforts should be made to engage these groups whenever possible and raise the issue of obesity treatment.

REFERENCES

1 Health Survey for England 2008. Physical Activity and Fitness - Volume 1. The NHS Information Centre, 2009.www.ic.nhs.uk/pubs/hse08physicalactivity

2 Guh DP, Zhang W, Bansback N et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88

3 Whitlock G, Lewington S, Sherliker P et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373(9669):1083-96

4 World Health Organization (WHO). Obesity: Preventing and Managing the Global Epidemic. Report on a WHO Consultation (WHO technical report series 894). WHO. Geneva. 2000

5 Taylor AE, Ebrahim S, Ben-Shlomo Y et al. Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr 2010; 91(3):547-556

6 Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17):2735-2752

7 WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403):157-163

8 Vazquez G, Duval S, Jacobs DR Jr et al. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007; 29:115-128

9 Kannel WB. Effect of weight on cardiovascular disease. Nutrition 1997; 13(2):157-158

10 Metwally M, Ong KJ, Ledger WL et al. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 2008; 90(3):714-726

11 Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 2006; 45(4):600-606

12 Lievense AM, Bierma-Zeinstra SM, Verhagen AP et al. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology 2002; 41(10): 1155-1162

13 Heslehurst N, Simpson H, Ells LJ et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 2008; 9(6):635-683

14 Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005; 99(4):1592-1599

15 Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175(7):661-666

16 Scottish Intercollegiate Guidelines Network. SIGN 115. Management of Obesity. NHS Quality Improvement Scotland. Edinburgh. 2010

17 Dixon JB, O'Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299(3):316-323

18 National Institute for Health and Clinical Evidence. CG 43. The prevention, identification, assessment and management of overweight and obesity in adults and children. NICE. London. 2007

USEFUL INFORMATION

For GPs

The National Obesity Forum

http://www.nationalobesityforum.org.uk/

The readiness ruler to assess willingness to change is available at:

www.healthscotland.com/uploads/documents/2976-Healthy_Living_Readiness_Ruler_2_pages.pdf

For patients

Helpful details on small dietary changes and recipes can be found at:

www.nhs.uk/change4life/Pages/Default.aspx